Nigeria Cancer Immunotherapy Market Analysis

Nigeria Cancer Immunotherapy Market Analysis


$ 3999

Nigeria's cancer immunotherapy market is expected to witness growth from $101 Mn in 2022 to $189 Mn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The increasing demand and the development of novel cancer treatment options are driving the growth of the Nigeria cancer immunotherapy market. The Nigeria cancer immunotherapy market is segmented by type, application, and end user. Drugfield Pharmaceuticals, Drugfield Pharmaceuticals, and Novartis are the major players in the Nigeria cancer immunotherapy market.

ID: IN10NGPH032 CATEGORY: Pharmaceuticals GEOGRAPHY: Nigeria AUTHOR: Dr. Parul Choudhary

Buy Now

Nigeria Cancer Immunotherapy Market Executive Analysis

Nigeria's cancer immunotherapy market is expected to witness growth from $101 Mn in 2022 to $189 Mn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The budget for healthcare went from $0.6 Bn in 2015 to $2.6 Bn in 2023, a 339.19% rise. increase in the national budget for health from 4.7 % in 2022 to 5.75 % in 2023; a 13.61 % reduction in the Basic Health Care Provision Fund (BHCPF) from $0.12 Bn in 2018 to $0.10 Bn in the proposed 2023 budget estimates; and an expansion of family planning (FP) services from 0 budget in 2022 to $43 Mn in 2023 to obtain commodities.

Over 72,000 people in Nigeria per year (30924 men and 40647 women) die from cancer. Given that there are 102,000 new instances of cancer each year, this number is expected to rise. Breast cancer is projected to occur at a rate of 27%, along with cancers of the cervix (14%), liver (12%), prostate (12%), and colorectum (4.1%). Compared to the liver (16%), prostate (13%), cervix uteri (12%), and colorectum (4.4%), breast cancer mortality is expected to be 20%. Currently, prostate cancer is the third most common cancer-related death in Nigeria, followed by liver cancer and breast cancer.

Immunotherapy is a form of medicine that targets specific immune system components to treat conditions like cancer. Immunotherapy has grown in importance as a component of various cancer treatments during the past few decades. New immunotherapy therapies are being evaluated and approved, and the understanding of how the immune system functions is expanding quickly. Some cancer types respond to immunotherapy more effectively than others. Some of these tumors are treated with it alone, but for others, it seems to function best when combined with other forms of therapy. Immunotherapy is used to treat cancer in a variety of ways, many of which are still being researched. Checkpoint inhibitors essentially remove the immune system's "brakes," enabling it to recognize and combat cancer cells. Chimeric antigen receptor (CAR) T-cell treatment removes a small number of T cells from the patient's blood, combines them with a unique virus that teaches the T cells how to adhere to tumor cells, and then returns the cells to the patient so they can locate, attach to, and eradicate cancer. To encourage the immune system to combat cancer, cytokines—small proteins that transmit messages between cells—are used.

Nigeria Cancer Immunotherapy Market Analysis

Market Dynamics

Market Growth Drivers

In Nigeria, cancer is a serious public health issue since it causes a large number of fatalities. Given that immunotherapy is one of the most promising cancer treatment options now accessible, the rising incidence of cancer in the nation is anticipated to increase demand for it. The Nigeria cancer immunotherapy market is anticipated to rise as a result of the development of novel immunotherapy medications and technology. In the upcoming years, it is anticipated that the country will adopt immune checkpoint inhibitors, CAR T-cell therapy, and other cutting-edge methods of cancer treatment more frequently.

Market Restraints

Nigeria's healthcare system is still in its early stages, and there aren't many resources accessible for cancer treatment. This may restrict the country's access to the availability of immunotherapy therapies for cancer patients. Numerous cancer patients in Nigeria might not be able to afford immunotherapy therapies because they are frequently expensive to buy. This may restrict the use of these therapies and restrict patients' access to treatments that could save their lives. When it comes to informed consent, patient autonomy, and equal access to care, immunotherapy treatments may raise ethical questions in Nigeria. These worries could restrict the use of these therapies and prevent patients from receiving the best care available therefore limiting the expansion of the Nigeria cancer immunotherapy market.

Competitive Landscape

Key Players

  • Emzor Pharmaceuticals (NGA)
  • Chemiron International (NGA)
  • Mopson Pharmaceuticals (NGA)
  • Drugfield Pharmaceuticals (NGA)
  • Drugfield Pharmaceuticals (NGA)
  • Novartis
  • Celgene
  • Amgen
  • Merck
  • Janssen
  • Seattle Genetics
  • Printers
  • Gritstone Oncology

Healthcare Policies and Regulatory Landscape

There is currently no universal healthcare coverage in Nigeria, as the country's healthcare system combines public and private healthcare providers. This can make it difficult for cancer patients to get the necessary treatments, such as immunotherapy. The Nigerian government has put in place a few initiatives to increase access to cancer care in the nation about cancer treatment coverage. For instance, the National Health Insurance Scheme (NHIS) offers health insurance protection to all who qualify, including those who are fighting cancer. However, the NHIS's coverage is constrained and might not cover immunotherapy or all other facets of cancer treatment. The Nigerian government has put in place a fee-for-service compensation system for healthcare providers in terms of reimbursement policies. Providers are paid under this system for the medical services they give patients. The rates of reimbursement for cancer therapies, including immunotherapy, could, nevertheless, be less than the true cost of giving the medication.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cancer Immunotherapy Segmentation

By Type (Revenue, USD Billion):

  • Monoclonal Antibodies
  • Cancer Vaccines
  • Checkpoint Inhibitors
  • Immunomodulators
  • PD-1/PD-L1
  • CTLA-4

By Application (Revenue, USD Billion):

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Melanoma
  • Others

By End User (Revenue, USD Billion):

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Cancer Research Centers

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Drugfield Pharmaceuticals, Drugfield Pharmaceuticals, and Novartis are the major players in the Nigeria cancer immunotherapy market.

The Nigeria cancer immunotherapy market is expected to grow from $101 Mn in 2022 to $189 Mn in 2030 with a CAGR of 8.1% for the forecasted year 2022-2030.

The Nigeria cancer immunotherapy market is segmented by type, application, and end user.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 22 December 2023
Updated by: Dr. Purav Gandhi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up